Dexamethasone - Moxifloxacin Pf (1 recalls

The FDA has published 1 recall involving Dexamethasone - Moxifloxacin Pf (1 since 2021. The latest was reported on 6 Jan 2021. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2021

Last 12 months0reported

Class I00% of total

Ongoing0latest 6 Jan 2021

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why dexamethasone - moxifloxacin pf (1 is recalled

Sterility1100%

Companies

Imprimis Njof1100%

By year

20211100%

All dexamethasone - moxifloxacin pf (1 recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
6 Jan 2021Drug	CLASS II	Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL recalled	Imprimis Njof	Sterility	Nationwide

Should you stop taking Dexamethasone - Moxifloxacin Pf (1?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.